Bio Technology General - BTGC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (1977)	1/14/2000 5:06:00 PM
From: Jim Oravetz	Read Replies (1) of 2028

Switzerland's Ares-Serono '99 Revs Seen Up 12-13% ZURICH -- Analysts expect Swiss drugs group Ares Serono SA (Z.ARS) to report a 12% to 13% increase in full-year 1999 sales Tuesday to between CHF1.029 billion and CHF1.037 billion. The increase is seen driven primarily by surges in sales of the group's recombinant drugs for multiple sclerosis (Rebif) and AIDS wasting (Serostim), which are estimated to have increased by 218% and 53%, respectively. www.drugstore.com/pharmacy/prices/drugprice.asp?back=%2Fsearch%2Fsearch%2Easp&drug=Serostim www.drugstore.com/pharmacy/prices/drugprice.asp?back=%2Fsearch%2Fsearch%2Easp&drug=Oxandrin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next